On October 17, 2023, Virax Biolabs Group Limited closed the transaction. The transaction included participation from a single investor.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.04 USD | 0.00% | +16.85% | -28.77% |
Chiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-28.77% | 2.46M | |
+45.48% | 56.65B | |
-6.93% | 39.44B | |
+39.19% | 39.03B | |
-6.65% | 26.86B | |
+12.37% | 26.75B | |
-21.01% | 19.03B | |
+0.89% | 12.28B | |
+24.40% | 12.26B | |
+26.93% | 12.04B |
- Stock Market
- Equities
- VRAX Stock
- News Virax Biolabs Group Limited
- Virax Biolabs Group Limited announced that it has received $2.15 million in funding